Cancer
Conditions
Interventions
Healthy group:None
Sponsors
The Second Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. For patients with ovarian cancer, breast cancer, pancreatic cancer, or prostate cancer after pathological diagnosis or clinical consideration, solid masses with a minimum of 1.5 cm can be seen by imaging methods. 2. Routine relevant checks have been completed, including the following: (1) 12-lead electrocardiogram, heart B-ultrasound; (2) Laboratory tests: blood routine, urine routine, liver function, kidney function, coagulation routine.
Exclusion criteria
Exclusion criteria: (1) Have participated in other clinical trials within 4 weeks before the start of this study; (2) Those who have no pathological results and no puncture or surgical plan; (3) Suffering from other major diseases (respiratory depression, (lung) airway obstruction or tissue hypoxia, biliary tract diseases, heart diseases, blood system diseases, brain diseases, cognitive impairment); (4) Patients with severe liver and kidney dysfunction (alanine aminotransferase exceeds the upper limit of normal value by 8-10 times, and serum creatinine is 186-442 µmol/L); (5) History of drug allergy, or discontinuation of a drug due to adverse reactions when using a drug; (6) drug and/or alcohol abuse; (7) Pregnant and lactating women; (8) Patients with pacemakers, nerve stimulators, artificial metal heart valves, etc.; Those with aneurysm clips (except for non-paramagnetic such as titanium alloys); Those who have intraocular metal foreign bodies, inner ear implants, metal prostheses, and ferromagnetic foreign bodies in the body.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immunohistochemical score;Standardized Uptake Value maximum, SUVmax; | — |
Countries
China
Contacts
Public ContactXiaowei Ma
The Second Xiangya Hospital of Central South University
Outcome results
None listed